Tech-Park Kaunas startup “BrachyDOSE” secures 0.5 million Eur investment to advance cancer treatment technology
Kaunas-based medical technology startup “BrachyDOSE”, a proud member of the Tech-Park Kaunas innovation community, has raised 554,000 Eur in funding to further develop and test its radiation measurement technology in real hospital settings. The investment round was supported by venture capital funds “Coinvest Capital” and “BSV Ventures”, alongside business angel networks “LitBAN” and “EstBAN”.
“BrachyDOSE” is developing a patient-centred ionising radiation dose measurement system designed to enable oncologists to monitor radiotherapy treatments with greater precision, helping to minimise side effects and improve treatment quality. This investment will allow the company to finalise its CE/MDR certification, a key milestone for medical devices entering the EU market. The need for such accurate, data-driven solutions is especially critical in oncology, where each detail of the treatment plan directly impacts patient outcomes.
The startup’s solution combines expertise in physics, engineering, medical device development and data analytics. Their system comprises a custom-designed dosimeter, a data-reading device, and specialised software that helps physicians create safer, more accurate treatment plans. The technology has the potential to be implemented in oncology hospitals around the world.
“BrachyDOSE” is already collaborating with leading Lithuanian cancer treatment institutions, including the National Cancer Institute at Santaros Clinics and the Oncology Hospital of the Lithuanian University of Health Sciences. The team is now preparing to expand its expert network and scale its operations in anticipation of full market entry following certification.
As an active member of the Tech-Park Kaunas startup ecosystem, “BrachyDOSE” is a strong example of how deep-tech ventures in Lithuania are contributing tangible innovation to global healthcare. Their progress marks a significant step forward for the country’s medical technology sector, with far-reaching benefits for patients and health systems alike.